Navigation Links
Quest for genes involved in celiac disease
Date:4/5/2011

This release is available in Spanish.

Celiac disease (CD) involves intolerance to gluten and, consequently, suffering chronic illness in the small intestine. It is a genetic disorder, the immunological indications of which can be traced in the human body prior to the everyday activities of future sufferers being affected. For example, persons with genetic antecedents for CD develop antibodies against the gene tTG (the enzyme known as tissue transglutaminase), even before the illness becomes active, due to a cell reaction against gluten.

The clinical symptoms of CD appear only in the final stages of the disease. This is why it is important to find the genes linked to it, thus facilitating an early diagnosis, as well as fighting against CD before it becomes an active illness. In effect, biologist Ms Ainara Castellanos has opened a door to the elucidation of this: her research was aimed at identifying genes that may have a functional involvement in the CD, developing a tool which, amongst other things, looked at the changes in gene expression. For example, she was able to verify that the gene known as UBD may be linked to CD. Her thesis, defended at the University of the Basque Country (UPV-EHU), is entitled, Functional players in celiac disease: identification and genetic association.

Intestinal biopsies at Cruces hospital

In order to undertake her research, Ms Castellanos used intestinal biopsies at the Hospital de Cruces (in Barakaldo, near the Basque city of Bilbao), drawing up a strategy that crossed data on gene levels of expression gathered from these biopsies, information about the anatomical regions closely linked to CD, and various bioinformatic instruments.

The research undertaken in this thesis confirmed that this tool, which takes levels of expression of the genes into account, is useful in identifying those which are especially susceptible to CD. In fact, thanks to the work, Ms Castellanos was able to distinguish, in the anatomical regions closely linked to CD, a number of genes subjected to alterations in their expression caused by gliadine (a protein that forms part of gluten), and she verified that these genes are candidates for being functionally involved with CD.

Besides this, based on information obtained from intestinal biopsies of the celiac patients, she was able to undertake an analysis and a general description of the alterations in expression caused by gliadine in the intestinal mucous. Given all this, Ms Castellanos concluded that, in those cases in which there is CD, malfunctions in intercellular communication, in intracellular signalling, in ubiquitine proteins and in a number of other networks are produced. Thus, she confirmed that CD is a complex and multifactorial illness. Moreover, on describing the changes happening with the levels of expression, she has provided guidelines on understanding how CD develops and found new factors which influence this progress of the disease.

Ubiquitine D

Amongst the networks mentioned previously, Ms Castellanos stressed the ubiquitine proteins, concretely ubiquitine D (UBD). An over-expression of UBD in the intestinal biopsies of the celiac patients and, in relation to this, a genetic variant or polymorphism linked to CD. As she explains in her thesis, this polymorphism could precisely be the inductor of this over-expression. Ms Castellanos stressed that the same could happen with other genes, candidates for being involved in CD. As a consequence, the example of UBD has confirmed that the observation of the genetic expressions can help in finding those genes which, while being unknown as yet, are linked to the onset of CD.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. U of A researcher questions whether genius might be a result of hormonal influences
2. UofL biostatistician to develop statistical model that could help answer medical questions
3. Experts question aspects of prescribed burning
4. Ancient teeth raise new questions about the origins of modern man
5. The quest for the ultimate blue cheese
6. New Anglo-Swiss research questions impact of GM wheat on insects
7. What is life? New answers to an age-old question in astrobiology
8. New UCLA study raises questions about genetic testing of newborns
9. To be or not to be endangered? Listing of rare Hawaiian coral species called into question
10. Scientists question fisheries health test
11. Scientists question indicator of fisheries health, evidence for fishing down food webs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... Calif. (PRWEB) , ... February 24, 2017 , ... Chef ... and wine scene. Making stops in several cities, she gained a number of ... adventure began in Stellenbosch, a town in South Africa’s Western Cape province. It ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
Breaking Biology Technology: